Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by WalkOverTheStrton Mar 08, 2021 9:32pm
135 Views
Post# 32749497

RE:RE:RE:RE:Markets Mixed

RE:RE:RE:RE:Markets Mixed@wounded kneee

1) You or the pundits on FN are not medical doctors that have examined Biden. Let alone FN did the same number on Hilary's health in the election runup... see a pattern... Also throwing stones after Trump's bizarre speeches and explanations is pot calling the kettle black...

2) Socialist nation?  You mean like Medicare, Medicaid and Social Security. Oh and don't forget bail outs to the banks and big corps at every crisis they help create... God forbid mainstreet gets some help after fronting the bill for bailouts countless times... 

3) My guess is this is all about fear that Biden will raise the capital gains tax. Unless you're one of the near 1% not sure the concern. Reuters article below. The stock market in general doesn't drive economic impact to the majority of Amercians. Not as a % of who is making the majority of value (ultra wealth, fin institutions, hedge funds). Not sure if you live in America but the wealth gap is increasing and the middle class is shrinking.. All i see are failed Republican policies (like trickle down that 99% economist agree doesn't work) and the recent corp tax break that only exacerbates this divide. If you aren't a multi millionaire it's not a concern to have. 
 
"Shared thousands of times on Facebook with less than a month until the Nov. 3 general election, posts on Facebook claim that Democratic presidential nominee Joe Biden’s “Capital Gains Tax means that when you sell your home you’ll owe taxes of 40% of your profit.” This claim is partly false: Biden plans to raise the capital gains tax only for those earning more than $1 million a year."
https://www.reuters.com/article/uk-factcheck-biden-capital-gains-tax/fact-check-biden-willonlytax-capital-gainsat-40for-those-earning-over-1-million-annually-idUSKBN26Z2CA 
<< Previous
Bullboard Posts
Next >>